Pack­a­ging spe­cia­list ALPLA’s pharma divi­sion growing

Fur­ther expan­sion due to acqui­si­tion of Polish com­pany APON

Hard, 7 July 2022 – The global pack­a­ging com­pany ALPLA is boos­ting the pre­sence of its pharma divi­sion in Cen­tral and Eas­tern Europe (CEE) with the acqui­si­tion of the Polish com­pany APON. APON pro­duces pla­stic pack­a­ging for the pharma industry at its site in Żyrardów near Warsaw. The acqui­si­tion con­ti­nues the growth and expan­sion course of the ALPLApharma busi­ness divi­sion estab­lished in 2019.

Bot­tles, con­tai­ners, caps, dosage sys­tems and access­ories in cer­ti­fied clean-room qua­lity – ALPLA has been pro­du­cing pla­stic pack­a­ging for pharma pro­ducts since 2016. The rapidly gro­wing seg­ment was con­so­li­dated under the brand ALPLApharma in 2019 and has been gra­du­ally expanded. ALPLA is con­ti­nuing this expan­sio­nary course with the acqui­si­tion of the Polish com­pany APON. ‘We are incre­asing our pre­sence in Cen­tral and Eas­tern Europe and are pro­vi­ding the emer­ging market in Poland and the Baltic states with high-quality pro­ducts right there in the region,’ explains Walter Knes, Mana­ging Director, ALPLApharma.

APON was founded as a family busi­ness in 1985. Its work­force of appro­xi­m­ately 45 at the site in Żyrardów near Warsaw curr­ently pro­duces bot­tles with fill volumes of 5 to 100 mil­li­li­tres, con­tai­ners with screw caps or snap lids and medical access­ories with dosage aids. The phar­maceu­tical pri­mary pack­a­ging is pro­duced in a clean room in accordance with ISO 15378.

The com­pany also pro­duces pack­a­ging for food sup­ple­ments and for the e‑liquid sector. The pla­s­tics used as pack­a­ging mate­rials are HDPE, LDPE, PP and PET. It has a total annual pro­duc­tion of over 200 mil­lion units. Its inte­gra­tion into the ALPLA Group is bene­fi­cial for both par­ties – in addi­tion to the deve­lo­p­ment of new mar­kets, it will allow for access to tech­no­lo­gical exper­tise and pack­a­ging inno­va­tions. All of the APON staff will be kept on.

Pharma, a future market
ALPLApharma has its main sites in Egypt, Greece, Romania, South Africa and Poland as well as pro­duc­tion plants in nine other count­ries. Fur­ther expan­sio­nary steps are planned in the months and years to come. Its port­folio will also be expanded. In addi­tion to stan­dard pro­ducts for the pharma industry, it focuses on pack­a­ging for over-the-counter (OTC) phar­maceu­ti­cals and food sup­ple­ments. ALPLApharma recently added fle­xible EBM (extru­sion blow moul­ding) tech­no­logy to its pro­duc­tion because of this, making it pos­sible for sus­tainable, weight-reduced and cost-effective con­tai­ners to be produced.

The Pharma divi­sion has huge future poten­tial. As well as above-average market growth, the seg­ment is cha­rac­te­rised by strong cus­tomer loyalty. With our global capa­ci­ties and qua­lity stan­dards, we make reliable and long-term part­ner­ships pos­sible,’ empha­sises ALPLA CEO Philipp Lehner.

The con­tract part­ners have agreed not to dis­c­lose any details of the acquisition.



About the ALPLA Group
ALPLA is one of the leading companies involved in plastic packaging and recycling. Around 22,100 employees worldwide produce custom-made packaging systems, bottles, caps and moulded parts at 177 sites across 45 countries. The high-quality packaging is used in a wide range of areas, including for food and drinks, cosmetics and care products, household cleaning products, detergents and cleaning agents, pharmaceutical products, engine oils and lubricants.

ALPLA operates recycling plants for PET and HDPE in Austria, Germany, Poland, Mexico, Italy, Spain, Romania and Thailand. Other projects are being realised elsewhere around the world.


Infor­ma­tion for editorial
ALPLA, Erik Nielsen (Senior Com­mu­ni­ca­tions Manager), tel.: +43 (0)5574 6021 701, email:
Pzwei. Pres­se­ar­beit, Joshua Köb, tel.: +43 (0)5574 4471 522, email: